Since BRAF gene mutations, which are a component of the RAF/MEK/ERK pathway, are commonly found in melanoma and papillary thyroid cancer, few studies have investigated its presence in PA [33,152,153,154]. This evidence concerns the gene BRAF and thyroid gland papillary carcinoma.